Gary Pigeau received his Ph.D. in Biotechnology from Brock University in St. Catharines, Ontario. He completed a postdoctoral fellowship at the University of Alberta with a visiting scientist appointment at the University of Oxford. Gary moved to private industry in 2008, where his research group focused on process development and scale-up of a proprietary bioprocess technology. He then moved to commercial, large-scale biomanufacturing in 2013. Gary joined Cytiva, formerly part of GE Healthcare’s Life Sciences business, and the Centre for Advanced Therapeutic Cell Technologies (CATCT) at CCRM in 2016. He serves as Director of the collaborative facility in Toronto, Ontario with focus on biology support for New Product Introductions, internal technology development projects and contract process development services in cell and gene therapy.
Recent Posts
- ChatGPT for CRISPR creates new gene-editing tools
- Moffitt Study Suggests Cells Possess Hidden Communication System
- Space-Made Fibers and Novel Biotech Among Research Returning to Earth After Successful Space Station Mission
- UNC-Chapel Hill researchers create artificial cells that act like living cells
- Providers Walgreens expands specialty pharmacy business to gene and cell therapy services
- Genetically engineering a treatment for incurable brain tumors